‍

COREangels Algarve, a group of angel investors bringing smart capital and collective intelligence to the Algarve startup ecosystem, and we are happy and proud to shout out loudly: we signed a SAFE with expressTEC, a pioneering biotech startup from the University of Algarve working on the next-generation RNA companion diagnostics for accurate, fast and simple cancer targeted treatment decisions. The SAFE was signed on September 11th, and is the first official deal of recently founded COREangels Algarve fund.

‍

“We invest more than euros — we invest operating know‑how and community,” said Wouter Heijnen at COREangels Algarve. “expressTEC fits our thesis of founder‑led innovation within the Algarve. With our angels’ experience, we’re excited to help the team to become successful on their ambitious goals with high societal but also personal impact for many.”

‍

“COREangels Algarve brings us seasoned and regional supporters” said Ana-Teresa Maia, co-founder & CEO of expressTEC. “The SAFE gives us the support we need now in the process of the release of our first product ExpressPIK, and the angels’ support gives us the confidence to execute our plans.”

‍

‍

More information:

expressTEC is a spin-off incubated at the University of Algarve and is proud to be a female founded technology-based company. Founded in 2022 by Ana Teresa Maia and Joana Xavier, PhD researchers with a combined experience of over 35 years in the field of cancer, expressTEC is dedicated to the development of complementary in-vitro diagnostic (IVD) genetic tests, with the aim of increase the accuracy and effectiveness of targeted treatments in oncology.

‍

COREangels Algarve is an angel investment group with the focus on supporting business in the South of Portugal. An eco-system that is thriving but young. COREangels Algarve is investing €50K-€200 in coachable founders, to whom angels can contribute and with whom we can co-create value, building startups connected to the ecosystem in pre-seed and seed stages. COREangels Algarve is part of an international group of angels investment funds - with 14 funds in total based on regions and/or verticals.